{
    "2021-09-06": [
        [
            {
                "time": "2021-09-06",
                "original_text": "恒瑞医药引进一款CD20抗体药物！并对天广实生物股权投资3000万美元！",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "CD20抗体",
                        "天广实生物",
                        "股权投资"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-06",
                "original_text": "9月6日恒瑞医药、欣旺达等10家公司公告出现利好",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "欣旺达",
                        "利好"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "其他行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-06",
                "original_text": "恒瑞医药子公司获药物临床试验批准通知",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "子公司",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-06",
                "original_text": "天广实与恒瑞医药达成战略合作，推进第三代CD20抗体商业化销售及联合用药合作",
                "features": {
                    "keywords": [
                        "天广实",
                        "恒瑞医药",
                        "战略合作",
                        "CD20抗体"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-06",
                "original_text": "西南证券：维持恒瑞医药“买入”评级 CD20单抗市场前景广阔",
                "features": {
                    "keywords": [
                        "西南证券",
                        "恒瑞医药",
                        "买入评级",
                        "CD20单抗"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-09-06",
                "original_text": "A股融资融券日报：两融余额减少64.16亿元（9月3日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "金融"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}